(202) 558-2030 info@nidellaw.com

A research paper published last year by scientists at the Johns Hopkins Bloomberg School of Public Health provided further evidence of a connection between pregnant mothers use of certain type of medications, known as selective seratonin reuptake inhibitors or “SSRIs”, used in the treatment of depression, anxiety, and other medical conditions, and an increased risk for offspring with autism spectrum disorder or ASD.  An association was also found between the use of these drugs and developmental delays in boys.  The article appeared in an online version of the Journal of Pediatrics.  The study demonstrated that the greatest risk is associated with prenatal SSRI use during the first trimester of pregnancy, where the risk of having an autistic boy was nearly 3-times greater than for those mothers that were not given the medication.

There are a number of other risks associated with taking these drugs during pregnancy including the risk of preterm birth, low birth weight, as well as children born with congenital heart defects, clubfoot,and other rare birth defects.  These medical findings require that doctors and patients be fully informed of the risks of starting or continuing one of these medications before or during a pregnancy so that the risks and benefits of drug use can be weighed as part of a healthy treatment regimen.

As the evidence continues to mount, Nidel Law, P.L.L.C. continues to investigate the potential relationship between these medications and the risk of having children with an ASD.  As we continue this investigation, we are interested in hearing from parents of children that have been diagnosed with autism spectrum diseases (ASD).

If you are a parent with a child that has been diagnosed with an autism spectrum condition and believe that it may be attributable to the use of an SSRI antidepressant during pregnancy, we ask that you please complete the following form.

You may have a claim against the manufacturers or distributors of these potentially dangerous drugs.